GMED Globus Medical, Inc.
Healthcare$85.10+0.34%ClosedMarket Cap: $11.48B
As of 2026-05-26
Valuation
P/E (TTM)
22.74
PEG
0.05
P/B
2.43
P/S
3.69
EV/EBITDA
12.40
DCF Value
$38.67
FCF Yield
5.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
67.9%
Operating Margin
17.6%
Net Margin
18.9%
ROE
13.0%
ROA
10.8%
ROIC
9.7%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $759.9M | 69.2% | $163.6M | $124.3M | $— | — |
| Q4 null | $826.4M | 72.0% | $171.7M | $140.6M | $— | — |
| FY null | $2.94B | 67.4% | $479.8M | $537.9M | $— | — |
| Q3 null | $769.0M | 63.3% | $135.0M | $119.0M | $— | — |
| Q2 null | $745.3M | 66.6% | $76.1M | $202.8M | $— | — |
| Q1 null | $598.1M | 67.3% | $97.0M | $75.5M | $— | — |
| Q4 null | $657.3M | 59.9% | $60.3M | $26.5M | $— | — |
| FY null | $2.52B | 58.9% | $166.0M | $103.0M | $— | — |
| Q3 null | $625.7M | 56.8% | $48.1M | $51.8M | $— | — |
| Q2 null | $629.7M | 58.7% | $49.6M | $31.8M | $— | — |
| Q1 null | $606.7M | 60.2% | $8.0M | $-7.1M | $— | — |
| Q4 2023 | $616.5M | 56.9% | $10.1M | $15.0M | $0.11 | — |